Old Web
English
Sign In
Acemap
>
authorDetail
>
Jacques Gaudreault
Jacques Gaudreault
Fox Chase Cancer Center
Medicine
Pharmacokinetics
Carboplatin
Bevacizumab
Area under the curve
4
Papers
2266
Citations
0.03
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits.
2007
Retina-the Journal of Retinal and Vitreous Diseases
Jacques Gaudreault
David T.W. Fei
Joseph C. Beyer
Anne M. Ryan
Linda Rangell
Vanessa Shiu
Lisa A. Damico
Show All
Source
Cite
Save
Citations (149)
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
2004
Journal of Clinical Oncology
David H. Johnson
Louis Fehrenbacher
William Novotny
R. S. Herbst
John Nemunaitis
David M. Jablons
Corey J. Langer
Russell F. DeVore
Jacques Gaudreault
Lisa A. Damico
Eric Holmgren
Fairooz F. Kabbinavar
Show All
Source
Cite
Save
Citations (1762)
Clinical pharmacokinetics of bevacizumab following every 2- or every 3-week dosing
2004
Journal of Clinical Oncology
Jacques Gaudreault
R. Bruno
Fairooz F. Kabbinavar
A. Sing
David H. Johnson
J. Lu
Show All
Source
Cite
Save
Citations (10)
Phase Ib Trial of Intravenous Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor in Combination With Chemotherapy in Patients With Advanced Cancer: Pharmacologic and Long-Term Safety Data
2001
Journal of Clinical Oncology
Kim Margolin
Michael S. Gordon
Eric Holmgren
Jacques Gaudreault
William Novotny
Gwen Fyfe
Daniel C. Adelman
S Stalter
J Breed
Show All
Source
Cite
Save
Citations (345)
1